» Articles » PMID: 11641277

Coilin Forms the Bridge Between Cajal Bodies and SMN, the Spinal Muscular Atrophy Protein

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 2001 Oct 20
PMID 11641277
Citations 120
Authors
Affiliations
Soon will be listed here.
Abstract

Spinal muscular atrophy (SMA) is a genetic disorder caused by mutations in the human survival of motor neuron 1 gene, SMN1. SMN protein is part of a large complex that is required for biogenesis of various small nuclear ribonucleoproteins (snRNPs). Here, we report that SMN interacts directly with the Cajal body signature protein, coilin, and that this interaction mediates recruitment of the SMN complex to Cajal bodies. Mutation or deletion of specific RG dipeptide residues within coilin inhibits the interaction both in vivo and in vitro. Interestingly, GST-pulldown experiments show that coilin also binds directly to SmB'. Competition studies show that coilin competes with SmB' for binding sites on SMN. Ectopic expression of SMN and coilin constructs in mouse embryonic fibroblasts lacking endogenous coilin confirms that recruitment of SMN and splicing snRNPs to Cajal bodies depends on the coilin C-terminal RG motif. A cardinal feature of SMA patient cells is a defect in the targeting of SMN to nuclear foci; our results uncover a role for coilin in this process.

Citing Articles

The Cajal body marker protein coilin is SUMOylated and possesses SUMO E3 ligase-like activity.

Lett K, McLaurin D, Tucker S, Hebert M Front RNA Res. 2024; 1.

PMID: 39703804 PMC: 11656447. DOI: 10.3389/frnar.2023.1197990.


In Search of Spinal Muscular Atrophy Disease Modifiers.

Chudakova D, Kuzenkova L, Fisenko A, Savostyanov K Int J Mol Sci. 2024; 25(20).

PMID: 39456991 PMC: 11508272. DOI: 10.3390/ijms252011210.


Ubiquitination Insight from Spinal Muscular Atrophy-From Pathogenesis to Therapy: A Muscle Perspective.

Bolado-Carrancio A, Tapia O, Rodriguez-Rey J Int J Mol Sci. 2024; 25(16).

PMID: 39201486 PMC: 11354275. DOI: 10.3390/ijms25168800.


Keep calm and reboot - how cells restart transcription after DNA damage and DNA repair.

Donnio L, Giglia-Mari G FEBS Lett. 2024; 599(2):275-294.

PMID: 38991979 PMC: 11771587. DOI: 10.1002/1873-3468.14964.


Exploring Aromatic Cage Flexibility Using Cosolvent Molecular Dynamics Simulations─An In-Silico Case Study of Tudor Domains.

Vorreiter C, Robaa D, Sippl W J Chem Inf Model. 2024; 64(11):4553-4569.

PMID: 38771194 PMC: 11167732. DOI: 10.1021/acs.jcim.4c00298.


References
1.
Buhler D, Raker V, Luhrmann R, Fischer U . Essential role for the tudor domain of SMN in spliceosomal U snRNP assembly: implications for spinal muscular atrophy. Hum Mol Genet. 1999; 8(13):2351-7. DOI: 10.1093/hmg/8.13.2351. View

2.
Liu Q, Fischer U, Wang F, Dreyfuss G . The spinal muscular atrophy disease gene product, SMN, and its associated protein SIP1 are in a complex with spliceosomal snRNP proteins. Cell. 1997; 90(6):1013-21. DOI: 10.1016/s0092-8674(00)80367-0. View

3.
Charroux B, Pellizzoni L, Perkinson R, Shevchenko A, Mann M, Dreyfuss G . Gemin3: A novel DEAD box protein that interacts with SMN, the spinal muscular atrophy gene product, and is a component of gems. J Cell Biol. 1999; 147(6):1181-94. PMC: 2168095. DOI: 10.1083/jcb.147.6.1181. View

4.
Hsieh-Li H, Chang J, Jong Y, Wu M, Wang N, Tsai C . A mouse model for spinal muscular atrophy. Nat Genet. 1999; 24(1):66-70. DOI: 10.1038/71709. View

5.
Monani U, Sendtner M, Coovert D, Parsons D, Andreassi C, Le T . The human centromeric survival motor neuron gene (SMN2) rescues embryonic lethality in Smn(-/-) mice and results in a mouse with spinal muscular atrophy. Hum Mol Genet. 2000; 9(3):333-9. DOI: 10.1093/hmg/9.3.333. View